Carregant...
IMMU-01. TEMOZOLOMIDE-RESISTANT CAR-T ENHANCES GLIOBLASTOMA CLEARANCE BY CONCURRENT CHEMOTHERAPY AND IMMUNOTHERAPY
Despite refinements in multimodal management of glioblastoma (GBM) patients, long-term problem-free survival is still dismal. Post resection GBM patients who are concurrently treated with radiation and chemotherapy had a modest median survival of 14. 6 months. Immunotherapy for GBM has often been co...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692404/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.460 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|